Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

Código QR

Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

Abstract Background Neoadjuvant chemoradiotherapy (nCRT) followed by surgery is a standard treatment modality for locally-advanced esophageal cancer. However, patients who achieve clinical complete response (cCR) after nCRT have been reported to have better prognosis. Further, the role of surgery in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jaehyeon Park, Ji Woon Yea, Se An Oh, Jae Won Park
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Esophageal cancer Meta-analysis Complete response Neoadjuvant chemoradiotherapy Medical physics. Medical radiology. Nuclear medicine R895-920 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/43bd0ea3267e4565a98232b64f865e4d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The role of haematological parameters in predicting the response to radical chemoradiotherapy in patients with anal squamous cell cancer
por: Stojanovic-Rundic Suzana, et al.
Publicado: (2021)

Factors associated with higher rate of Complete Pathologic Response after Long-Course Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients – Results from a retrospective cohort study focused on Inflammatory Indexes
por: Carlos Cerdan-Santacruz, et al.
Publicado: (2021)

Prognostic Value of the Distribution of Lymph Node Metastasis in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy
por: Bin Chen, et al.
Publicado: (2021)

Effectiveness and Safety of Targeted Agents Combined With Chemoradiotherapy for the Treatment of Esophageal Cancer: A Network Meta-Analysis
por: Peng Liu, et al.
Publicado: (2021)

Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience
por: Vrankar Martina, et al.
Publicado: (2021)

Radiation boost for synchronous solitary inguinal lymph node metastasis during neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Mo Chen, et al.
Publicado: (2021)

Amifostine- and chemoradiotherapy-related esophagitis in small cell lung cancer: a single institutional series and literature update
por: Pollock AE, et al.
Publicado: (2018)

Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype
por: Cornelis M. de Mooij, et al.
Publicado: (2021)

THE COMPLETE CLINICAL RESPONSE IN RECTAL CARCINOMA AFTER CHEMO RADIATION
por: Ammara Manzoor, et al.
Publicado: (2018)

The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ–Ⅲ esophageal cancer: a SEER‐based demographic analysis
por: Hao Lv, et al.
Publicado: (2021)

Pneumatosis Intestinalis following Radiation Esophagitis during Chemoradiotherapy for Lung Cancer: A Case Report
por: Noriaki Ito, et al.
Publicado: (2021)

Communicating imaging findings in peritoneal mesothelioma: the impact of ‘PAUSE’ on surgical decision-making
por: Anuradha Chandramohan, et al.
Publicado: (2021)

Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
por: Ana Julia Aguiar de Freitas, et al.
Publicado: (2021)

Efficacy of concurrent chemoradiotherapy in subgroups of stage III nasopharyngeal carcinoma: an analysis based on 10-year follow-up
por: Lei Wang, et al.
Publicado: (2021)

Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study
por: Jeong Yun Jang, et al.
Publicado: (2021)

Long-Term Efficacy of Neoadjuvant Concurrent Chemoradiotherapy for Potentially Resectable Advanced Siewert Type II and III Adenocarcinomas of the Esophagogastric Junction
por: Yuan Tian, et al.
Publicado: (2021)

Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density
por: Xu Y, et al.
Publicado: (2021)

Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients
por: Chanon Puttanawarut, et al.
Publicado: (2021)

Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram
por: Hao Cui, et al.
Publicado: (2021)

Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
por: Jin Hong, et al.
Publicado: (2021)

Late Toxicities, Failure Patterns, Local Tumor Control, and Survival of Esophageal Squamous Cell Carcinoma Patients After Chemoradiotherapy With a Simultaneous Integrated Boost: A 5-Year Phase II Study
por: Chuangzhen Chen, et al.
Publicado: (2021)

Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
por: Jia-yi Li, et al.
Publicado: (2021)

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Yunhai Li, et al.
Publicado: (2021)

A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis
por: Yang Li, et al.
Publicado: (2021)

Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence
por: Jason Chia‐Hsun Hsieh, et al.
Publicado: (2021)

Retraction Note to: Diffusion-weighted MR imaging of locally advanced breast carcinoma: the optimal time window of predicting the early response to neoadjuvant chemotherapy
por: Li Yuan, et al.
Publicado: (2021)

Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
por: Catherine R. Hanna, et al.
Publicado: (2021)

Preoperative intensity-modulated chemoradiotherapy with simultaneous integrated boost in rectal cancer: five-year follow-up results of a phase II study
por: But-Hadzic Jasna, et al.
Publicado: (2021)

Concurrent chemoradiation therapy tailored to the older adults with esophageal cancer: state of the art and the future
por: Song T, et al.
Publicado: (2018)

Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis
por: Meng Yuan, et al.
Publicado: (2021)

Trimodality therapy for esophageal cancer: The role of surgical and radiation treatment parameters in the development of anastomotic complications
por: Salem Alfaifi, et al.
Publicado: (2021)

Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study
por: Peng Yang, et al.
Publicado: (2021)

MitomiRs: their roles in mitochondria and importance in cancer cell metabolism
por: Rencelj Andrej, et al.
Publicado: (2021)

A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
por: Du Y, et al.
Publicado: (2018)

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial
por: Mitsuro Kanda, et al.
Publicado: (2021)

A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the Elderly
por: SuPing Guo, et al.
Publicado: (2021)

Late orbital metastasis from colon cancer complicated by multiple tumors in the breast, lung, liver, and spine
por: Kensaku Makino, MD, et al.
Publicado: (2022)

Prognostic Significance of EMVI in Rectal Cancer in a Tertiary Cancer Hospital in India
por: Sayali Y. Pangarkar, et al.
Publicado: (2021)

Missed pathological femoral neck fracture undergoes spontaneous healing
por: Adrian C. Kong, MS, et al.
Publicado: (2022)

Esophageal cancer principles and practice /
Publicado: (2009)